{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:36:23Z","timestamp":1787283383606,"version":"build-2736575974"},"reference-count":29,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Submacular hemorrhage (SMH) is a vision-threatening condition most associated with neovascular age-related macular degeneration (nAMD), although it may also arise from polypoidal choroidal vasculopathy, pathological myopia, retinal vascular diseases, trauma, and systemic factors. Rapid management is essential because subretinal blood induces photoreceptor toxicity, clot organization, and fibroglial scarring, leading to irreversible visual loss. The choice and urgency of treatment depend on hemorrhage size, duration, and underlying pathology, and the patient\u2019s surgical risk category, which can influence the invasiveness of the selected procedure. This review aims to provide an updated synthesis of recent advances in the surgical and pharmacological management of SMH, focusing on evidence from the past five years and comparing outcomes across major interventional approaches. Methods: A narrative review of 27 recent clinical and multicentre studies was conducted. The included literature evaluated pneumatic displacement (PD), pars plana vitrectomy (PPV), subretinal or intravitreal recombinant tissue plasminogen activator (rtPA), anti-VEGF therapy, and hybrid techniques. Studies were analyzed about indications, surgical methods, timing of intervention, anatomical and functional outcomes, and complication and patient risk stratification. Results: Outcomes varied depending on the size and duration of hemorrhage, as well as the activity of underlying macular neovascularization. PD with intravitreal rtPA was reported as effective for small and recent SMH. PPV combined with subretinal rtPA, filtered air, and anti-VEGF therapy demonstrated favorable displacement and visual outcomes in medium to large hemorrhages or those associated with active nAMD. Hybrid techniques further improved clot mobilization in selected cases. Across studies, delayed intervention beyond 14 days correlated with reduced visual recovery due to blood organization and photoreceptor loss. Potential risks, including recurrent bleeding and rtPA-associated toxicity, were reported but varied across studies. Conclusions: Management should be individualized, considering hemorrhage characteristics and surgical risk. Laser therapy, including PDT, may serve as an adjunct in the perioperative or postoperative period, particularly in PCV patients. Early, tailored intervention typically yields the best functional outcomes.<\/jats:p>","DOI":"10.3390\/jcm15020469","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:46:43Z","timestamp":1767786403000},"page":"469","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Submacular Hemorrhage Management: Evolving Strategies from Pharmacologic Displacement to Surgical Intervention"],"prefix":"10.3390","volume":"15","author":[{"given":"Monika","family":"Sarna","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Wojew\u00f3dzkie Centrum Szpitalne Kotliny Jeleniog\u00f3rskiej, 58-506 Jelenia G\u00f3ra, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4950-6390","authenticated-orcid":false,"given":"Arleta","family":"Waszczykowska","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of Lodz, Kopcinskiego 22, 90-153 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.4103\/IJO.IJO_2295_23","article-title":"A novel technique for extensive submacular hemorrhage using high-dose tissue plasminogen activator","volume":"72","author":"Chauhan","year":"2024","journal-title":"Indian. J. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hillenmayer, A., Wertheimer, C.M., Hillenmayer, M., Strehle, L.D., Hartmann, L.M., Vounotrypidis, E., and Wolf, A. (2024). Comparison of different treatment options in submacular haemorrhage. BMC Ophthalmol., 24.","DOI":"10.1186\/s12886-024-03794-y"},{"key":"ref_3","first-page":"3160963","article-title":"Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm","volume":"2021","author":"Dewilde","year":"2021","journal-title":"J. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ophtha.2023.04.014","article-title":"Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study: A Randomized Controlled Trial for Submacular Hemorrhage Secondary to Age-Related Macular Degeneration","volume":"130","author":"Gabrielle","year":"2023","journal-title":"Ophthalmology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Barzelay, A., Daniels, A., Cohen, G.Y., Barak, A., Schwartz, S., and Katz, G. (2024). Pneumatic displacement with intravitreal tPA injection versus vitrectomy with sub retinal tPA injection in small and medium sub macular hemorrhages\u2014A multicenter comparative study. BMC Ophthalmol., 24.","DOI":"10.1186\/s12886-024-03468-9"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000537953","article-title":"Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study","volume":"247","author":"Szeto","year":"2024","journal-title":"Ophthalmologica"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41433-022-02222-z","article-title":"Na\u00efve subretinal haemorrhage due to neovascular age-related macular degeneration. pneumatic displacement, subretinal air, and tissue plasminogen activator: Subretinal vs. intravitreal aflibercept-the native study","volume":"37","author":"Iglicki","year":"2023","journal-title":"Eye"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4103\/ijo.IJO_1987_22","article-title":"Real-world outcomes and complications of different surgical approaches for significant submacular haemorrhages","volume":"71","author":"Boral","year":"2023","journal-title":"Indian J. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Patikulsila, D., Winaikosol, P., Choovuthayakorn, J., Watanachai, N., Chaikitmongkol, V., and Kunavisarut, P. (2022). Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: A case series. BMC Ophthalmol., 22.","DOI":"10.1186\/s12886-022-02639-w"},{"key":"ref_10","first-page":"39","article-title":"Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD\u2014Case series","volume":"126","author":"Nowosielska","year":"2024","journal-title":"Klin. Ocz. Acta Ophthalmol. Pol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ma, Y., Rao, S., Tan, Y., Du, H., and Sun, X. (2024). Combined treatment of submacular hemorrhage with low-dose subretinal recombinant tissue plasminogen activator and intravitreal conbercept. BMC Ophthalmol., 24.","DOI":"10.1186\/s12886-024-03660-x"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40942-019-0200-0","article-title":"Traumatic submacular hemorrhage: Available treatment options and synthesis of the literature","volume":"5","author":"Casini","year":"2019","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.4103\/ijo.IJO_1729_19","article-title":"Long-term clinical outcomes of submacular blood removal with isolated autologous retinal pigment epithelium-choroid patch graft transplantation in long-standing large-sized submacular hematomas: An Indian experience","volume":"68","author":"Boral","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Tripepi, D., Jalil, A., Ally, N., Buzzi, M., Moussa, G., Rothschild, P.R., Rossi, T., Ferrara, M., and Romano, M.R. (2023). The Role of Subretinal Injection in Ophthalmic Surgery: Therapeutic Agent. Delivery and Other Indications. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310535"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3928\/23258160-20161219-04","article-title":"Intravitreal Versus Subretinal Tissue Plasminogen Activator Injection for Submacular Hemorrhage","volume":"48","author":"Bell","year":"2017","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archopht.1991.01080050134044","article-title":"Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes","volume":"109","author":"Irvine","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/IAE.0000000000001029","article-title":"Novel Technique for Subretinal Injection Using Local Removal of the Internal Limiting Membrane","volume":"36","author":"Okanouchi","year":"2016","journal-title":"Retina"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ajo.2013.01.012","article-title":"Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy","volume":"155","author":"Shienbaum","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ajo.2013.04.029","article-title":"Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy","volume":"156","author":"Cho","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4103\/0301-4738.119432","article-title":"Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration","volume":"61","author":"Jain","year":"2013","journal-title":"Indian J. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archopht.121.1.91","article-title":"Pathogenesis of the vitreous cloud emanating from subretinal hemorrhage","volume":"121","author":"Lincoff","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00417-011-1649-1","article-title":"Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator","volume":"249","author":"Mizutani","year":"2011","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0002-9394(99)00474-2","article-title":"Vitreous hemorrhage after intravitreal tissue plasminogen activator (t-PA) and pneumatic displacement of submacular hemorrhage","volume":"129","author":"Kokame","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.iae.0000231544.43093.40","article-title":"Pneumatic displacement of submacular hemorrhage: Safety, efficacy, and patient selection","volume":"27","author":"Gopalakrishan","year":"2007","journal-title":"Retina"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s004170050232","article-title":"Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas","volume":"237","author":"Hesse","year":"1999","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/IAE.0b013e318287d99d","article-title":"Comparison of pneumatic displacement for submacular hemorrhages with gas alone and gas plus tissue plasminogen activator","volume":"33","author":"Fujikawa","year":"2013","journal-title":"Retina"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(97)00089-1","article-title":"Pathophysiology and management of subretinal hemorrhage","volume":"42","author":"Hochman","year":"1997","journal-title":"Surv. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ajo.2014.02.007","article-title":"Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration","volume":"157","author":"Chang","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/IAE.0000000000002384","article-title":"Posttreatment Polyp Regression and Risk of Massive Submacular Hemorrhage in Eyes with Polypoidal Choroidal Vasculopathy","volume":"40","author":"Cho","year":"2020","journal-title":"Retina"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/469\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:18:24Z","timestamp":1767935904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15020469"],"URL":"https:\/\/doi.org\/10.3390\/jcm15020469","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}